Published in J Immunol on October 01, 1981
Development trends for human monoclonal antibody therapeutics. Nat Rev Drug Discov (2010) 4.47
A rapid and efficient single-cell manipulation method for screening antigen-specific antibody-secreting cells from human peripheral blood. Nat Med (2009) 2.24
Human hybridomas constructed with antigen-specific Epstein-Barr virus-transformed cell lines. Proc Natl Acad Sci U S A (1982) 1.73
An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies. J Immunol Methods (2008) 1.61
UC 729-6, a human lymphoblastoid B-cell line useful for generating antibody-secreting human-human hybridomas. Proc Natl Acad Sci U S A (1983) 1.54
Monoclonal antibodies as probes of tetanus toxin structure and function. Infect Immun (1983) 1.34
Human antibody to OFA-I, a tumor antigen, produced in vitro by Epstein-Barr virus-transformed human B-lymphoid cell lines. Proc Natl Acad Sci U S A (1982) 1.21
Efficient generation in vitro, from human peripheral blood cells, of monoclonal Epstein-Barr virus transformants producing specific antibody to a variety of antigens without prior deliberate immunization. Proc Natl Acad Sci U S A (1983) 1.20
Epstein-Barr virus-transformed lymphocytes produce monoclonal autoantibodies that react with antigens in multiple organs. J Virol (1984) 1.19
Mining human antibody repertoires. MAbs (2010) 0.92
Human monoclonal antibodies against Mycobacterium leprae. Infect Immun (1985) 0.89
Requirements for growth of Epstein-Barr virus-transformed cells at low cell densities. Immunology (1987) 0.86
HAB-1, a new heteromyeloma for continuous production of human monoclonal antibodies. Br J Cancer (1990) 0.81
Characterization of human hybridomas secreting antibody to tetanus toxoid. Proc Natl Acad Sci U S A (1983) 0.79
Two neutralizing human anti-RSV antibodies: cloning, expression, and characterization. Mol Med (1999) 0.77
Requirements for the production of high-titre C3 nephritic factor (NEF) antibody in vitro. Immunology (1992) 0.75
The Cloning and Expression of Human Monoclonal Antibodies: Implications for Allergen Immunotherapy. Curr Allergy Asthma Rep (2016) 0.75
Monoclonal antibodies to Leptospira interrogans serovar pomona. Can J Comp Med (1985) 0.75
Effective production of anti-tetanus toxoid and anti-HBsAg human monoclonal antibodies by serum-free culture of hybridomas. Cytotechnology (1991) 0.75
Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci U S A (1993) 20.33
A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron (1999) 3.50
Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP. J Neurosci (1997) 2.89
Chemical induction of mGluR5- and protein synthesis--dependent long-term depression in hippocampal area CA1. J Neurophysiol (2001) 2.76
Target-effector interaction in the natural killer (NK) cell system. II. The isolation of NK cells and studies on the mechanism of killing. J Immunol (1978) 2.29
CAKbeta/Pyk2 kinase is a signaling link for induction of long-term potentiation in CA1 hippocampus. Neuron (2001) 2.22
The beige mutation in the mouse. I. A stem cell predetermined impairment in natural killer cell function. J Immunol (1979) 2.11
The receptor tyrosine kinase EphB2 regulates NMDA-dependent synaptic function. Neuron (2001) 2.02
The beige mutation in the mouse. II. Selectivity of the natural killer (NK) cell defect. J Immunol (1979) 2.02
Src activation in the induction of long-term potentiation in CA1 hippocampal neurons. Science (1998) 1.81
A new immunodeficiency disorder in humans involving NK cells. Nature (1980) 1.78
Recognition of myelin-associated glycoprotein by the monoclonal antibody HNK-1. Nature (1984) 1.77
Regulation of T cell activation, anxiety, and male aggression by RGS2. Proc Natl Acad Sci U S A (2000) 1.73
Human hybridomas constructed with antigen-specific Epstein-Barr virus-transformed cell lines. Proc Natl Acad Sci U S A (1982) 1.73
Target-effector interaction in the natural killer cell system: isolation of target structures. Proc Natl Acad Sci U S A (1979) 1.71
Target--effector interaction in the natural killer cell system. I. Covariance and genetic control of cytolytic and target-cell-binding subpopulations in the mouse. Scand J Immunol (1978) 1.70
Amplification of the c-myc oncogene in one of five human breast carcinoma cell lines. Cancer Res (1984) 1.54
Low natural in vivo resistance to syngeneic leukaemias in natural killer-deficient mice. Nature (1980) 1.42
Natural killer cells. Prog Allergy (1981) 1.38
Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1-targeted mice. Genes Brain Behav (2007) 1.37
High level functional engraftment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GM1. J Immunol Methods (1994) 1.32
Evidence that many of the DISC1 isoforms in C57BL/6J mice are also expressed in 129S6/SvEv mice. Mol Psychiatry (2007) 1.32
Recombinant myelin-associated glycoprotein confers neural adhesion and neurite outgrowth function. Neuron (1989) 1.25
Protective role of beta-chemokines associated with HIV-specific Th responses against perinatal HIV transmission. J Immunol (1999) 1.24
Chemiluminescence response of human natural killer cells. I. The relationship between target cell binding, chemiluminescence, and cytolysis. J Exp Med (1982) 1.23
Oxygen intermediates are triggered early in the cytolytic pathway of human NK cells. Nature (1982) 1.22
Target-effector interaction in the natural killer cell system. IV. Modulation by cyclic nucleotides. J Immunol (1979) 1.20
An expanded population of natural killer cells in mice with severe combined immunodeficiency (SCID) lack rearrangement and expression of T cell receptor genes. J Exp Med (1986) 1.19
Organization of a repetitive human 1.8 kb KpnI sequence localized in the heterochromatin of chromosome 15. Chromosoma (1985) 1.19
Modulation of NMDA receptors by pituitary adenylate cyclase activating peptide in CA1 neurons requires G alpha q, protein kinase C, and activation of Src. J Neurosci (2005) 1.18
Target-effector cell interaction in the natural killer cell system. V. Energy requirements, membrane integrity, and the possible involvement of lysosomal enzymes. Immunology (1980) 1.15
Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells. J Immunol (1987) 1.13
Studies of human natural killer cells. II. Analysis at the single cell level. J Immunol (1982) 1.13
A functional comparison of tumor cell killing by activated macrophages and natural killer cells. Eur J Immunol (1979) 1.12
Binding specificities of the sialoadhesin family of I-type lectins. Sialic acid linkage and substructure requirements for binding of myelin-associated glycoprotein, Schwann cell myelin protein, and sialoadhesin. J Biol Chem (1997) 1.12
The biology of the human natural killer cell. J Clin Immunol (1982) 1.11
Inducible cellular transformation by a metallothionein-ras hybrid oncogene leads to natural killer cell susceptibility. Nature (1986) 1.11
Impaired cerebellar synaptic plasticity and motor performance in mice lacking the mGluR4 subtype of metabotropic glutamate receptor. J Neurosci (1996) 1.11
Suppressor cells in immunosenescence. Fed Proc (1978) 1.08
Intra-rectal injection of tumour cells: a novel animal model of rectal cancer. Surg Oncol (1992) 1.06
Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma. Hybridoma (1982) 1.04
Enhanced dopamine function in DISC1-L100P mutant mice: implications for schizophrenia. Genes Brain Behav (2010) 1.04
Multiple behavioral anomalies in GluR2 mutant mice exhibiting enhanced LTP. Behav Brain Res (1998) 1.03
Photodynamic therapy augments the efficacy of oncolytic vaccinia virus against primary and metastatic tumours in mice. Br J Cancer (2011) 1.03
Src potentiation of NMDA receptors in hippocampal and spinal neurons is not mediated by reducing zinc inhibition. J Neurosci (1999) 1.03
Establishment of a human large cell lung tumor line (QU-DB) with metastatic properties in athymic mice. Cancer (1986) 1.01
The Lurcher mutation of an alpha-amino-3-hydroxy-5-methyl- 4-isoxazolepropionic acid receptor subunit enhances potency of glutamate and converts an antagonist to an agonist. J Biol Chem (2000) 1.01
Cytokine patterns during progression to AIDS in children with perinatal HIV infection. J Immunol (1995) 1.01
The EBV-hybridoma technique. Methods Enzymol (1986) 1.00
Diminished HIV-specific CTL activity is associated with lower type 1 and enhanced type 2 responses to HIV-specific peptides during perinatal HIV infection. J Immunol (1997) 1.00
Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology. J Clin Invest (1982) 1.00
Decreased neuronal Na+, K+ -ATPase activity in Atp1a3 heterozygous mice increases susceptibility to depression-like endophenotypes by chronic variable stress. Genes Brain Behav (2011) 1.00
Myelin-associated glycoprotein, a cell adhesion molecule of oligodendrocytes, is phosphorylated in brain. Mol Cell Biol (1988) 0.99
Spatial learning in transgenic mice expressing human presenilin 1 (PS1) transgenes. Neurobiol Aging (2000) 0.98
Establishment of anti-TNP antibody-producing human lymphoid lines by preselection for hapten binding followed by EBV transformation. Scand J Immunol (1979) 0.98
Differential splicing of MAG transcripts during CNS and PNS development. Brain Res (1988) 0.98
T cell activation and cellular cooperation in autoimmune NZB/NZW F hybrid mice. J Immunol (1975) 0.98
Induction of NMDA receptor-dependent long-term depression in visual cortex does not require metabotropic glutamate receptors. J Neurophysiol (1999) 0.96
Curdlan sulphate in human severe/cerebral Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg (2005) 0.96
The gene encoding the T4 antigen maps to human chromosome 12. J Immunol (1986) 0.95
Myelin-associated glycoprotein binding to gangliosides. Structural specificity and functional implications. Ann N Y Acad Sci (1998) 0.95
Systemic administration of ciliary neurotrophic factor induces cachexia in rodents. J Clin Invest (1994) 0.95
Regulation of the immune response in autoimmune NZB/NZW F1 mice. I. The spontaneous generation of splenic suppressor cells. Cell Immunol (1977) 0.95
Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein. Virology (2000) 0.94
Forward genetic screen of mouse reveals dominant missense mutation in the P/Q-type voltage-dependent calcium channel, CACNA1A. Genes Brain Behav (2007) 0.94
Class I (H-2Kb) gene transfection reduces susceptibility of YAC-1 lymphoma targets to natural killer cells. Eur J Immunol (1990) 0.94
Association between HIV-specific T helper responses and CTL activities in pediatric AIDS. Eur J Immunol (2000) 0.93
In vitro NK-activity and in vivo resistance to leukemia: studies of beige, beige//nude and wild-type hosts on C57BL background. Int J Cancer (1980) 0.93
Natural killer cell-mediated lysis involves an hydroxyl radical-dependent step. J Immunol (1985) 0.92
Oxygen intermediates are required for interferon activation of NK cells. J Interferon Res (1983) 0.92
Regulation of the autoimmune plaque-forming cell response to single-strand DNA (sDNA) in vitro. J Immunol (1978) 0.91
Differential involvement of the mu and kappa opioid receptors in spatial learning. Genes Brain Behav (2003) 0.91
An exoglycosidase-sensitive triggering site on NK cells which is coupled to transmethylation of membrane phospholipids. J Immunol (1985) 0.91
Synthesis of soluble myelin-associated glycoprotein in insect and mammalian cells. Gene (1989) 0.91
Spontaneous and induced primary oncogenesis in natural killer (NK)-cell-deficient beige mutant mice. Int J Cancer (1985) 0.90
Human monoclonal antibodies against Mycobacterium leprae. Infect Immun (1985) 0.89
The influence of glutamate receptor 2 expression on excitotoxicity in Glur2 null mutant mice. J Neurosci (2001) 0.88
Glial overexpression of NGF enhances neuropathic pain and adrenergic sprouting into DRG following chronic sciatic constriction in mice. Neurosci Lett (1998) 0.87
Adhesion properties of a neuronal epitope recognized by the monoclonal antibody HNK-1. Brain Res (1986) 0.87
Immunological senescence. I. The role of suppressor cells. Immunology (1978) 0.87
Differential expression of the Leu-7 antigen on human lung tumor cells. Cancer Res (1985) 0.86
Enhanced human immunodeficiency virus infection in macrophages by high-molecular-weight dextran sulfate is associated with conformational changes of gp120 and expression of the CCR5 receptor. Viral Immunol (1999) 0.86
Regulation of myelin-associated glycoprotein binding by sialylated cis-ligands. J Neurochem (1997) 0.85
Genetic loss of D-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice. Genes Brain Behav (2009) 0.85
Over-expression of the DM-20 myelin proteolipid causes central nervous system demyelination in transgenic mice. J Neurochem (1995) 0.85
A comparative analysis of the phenotypic characteristics of available fusion partners for the construction of human hybridomas. Hybridoma (1983) 0.85
Evidence for B cell-mediated activation of V delta 1+ T lymphocytes during progression of HIV infection. J Immunol (1997) 0.85
Synaptic modulators Nrxn1 and Nrxn3 are disregulated in a Disc1 mouse model of schizophrenia. Mol Psychiatry (2011) 0.85
Expression of members of immunoglobulin gene family in somatic cell hybrids between human B and T cells. Proc Natl Acad Sci U S A (1987) 0.84
Localization of CNTF immunoreactivity to neurons and astroglia in the CNS. Brain Res Mol Brain Res (1994) 0.84
Beta N-acetylglucosaminyltransferase V (Mgat5) deficiency reduces the depression-like phenotype in mice. Genes Brain Behav (2007) 0.84
The characterization and cellular distribution of a family of antigens related to myelin associated glycoprotein in the developing nervous system. J Neuroimmunol (1985) 0.84
A strategy for the production of human monoclonal antibodies reactive with lung tumor cell lines. Cancer Res (1984) 0.84